Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management

Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by...

Full description

Saved in:
Bibliographic Details
Published in:Disease-a-month 2024-01, Vol.70 (1), p.101674-101674, Article 101674
Main Authors: Manuelyan, Zara, Butt, Edward, Parupudi, Sreeram
Format: Article
Language:English
Subjects:
Behçet's disease
disease activity index for intestinal Behçet's disease
Intestinal Behçet's
Therapeutic regimen
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3
cites cdi_FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3
container_end_page 101674
container_issue 1
container_start_page 101674
container_title Disease-a-month
container_volume 70
creator Manuelyan, Zara
Butt, Edward
Parupudi, Sreeram
description Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by the ileocecal region. Diagnosis is challenging given lack of pathognomonic tests; therefore, it is based on clinical criteria. Management of intestinal BD includes different classes of medications including corticosteroids, 5-aminosalicylic acid, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody agents. In this review, we aim to focus on intestinal BD and provide details of clinical manifestations, diagnosis and therapeutic options of intestinal BD from gastroenterology viewpoint.
doi_str_mv 10.1016/j.disamonth.2023.101674
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2911844875</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0011502923001542</els_id><sourcerecordid>2911844875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3</originalsourceid><addsrcrecordid>eNqFkE1OwzAQhS0EoqVwBcgOFqTYzp_DrlRQkFqxgbXl2JPWVWJD7CJxIg7CxXBJ6ZbVzHjezBt_CF0QPCaY5DfrsdJOtNb41Zhimvy-FukBGpIsK2JGyvQQDTEmJM4wLQfoxLl1KGmZ4WM0SBhhWY6TIVrMhPOd1caD89qIJrqD1fcX-EsXBQsQDm6jhTC6Dn3htTXuOjTE0linQyqMilphxBJaMP4UHdWicXC2iyP0-nD_Mn2M58-zp-lkHsukID6umCIlFeEyEHkdgpQyrTFjNcmIhESpXJWyIsBKyHOqpKxYUkoqi1TiTEAyQlf93rfOvm_CZbzVTkLTCAN24zgtCWFpyoosSIteKjvrXAc1f-t0K7pPTjDfUuNrvmfJtyx5zzJMnu9MNlULaj_3By8IJr0Awlc_NHTcSQ1GgtIdSM-V1f-a_ADwDItW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2911844875</pqid></control><display><type>article</type><title>Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management</title><source>ScienceDirect Freedom Collection</source><creator>Manuelyan, Zara ; Butt, Edward ; Parupudi, Sreeram</creator><creatorcontrib>Manuelyan, Zara ; Butt, Edward ; Parupudi, Sreeram</creatorcontrib><description>Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by the ileocecal region. Diagnosis is challenging given lack of pathognomonic tests; therefore, it is based on clinical criteria. Management of intestinal BD includes different classes of medications including corticosteroids, 5-aminosalicylic acid, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody agents. In this review, we aim to focus on intestinal BD and provide details of clinical manifestations, diagnosis and therapeutic options of intestinal BD from gastroenterology viewpoint.</description><identifier>ISSN: 0011-5029</identifier><identifier>EISSN: 1557-8194</identifier><identifier>DOI: 10.1016/j.disamonth.2023.101674</identifier><identifier>PMID: 38185603</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Behçet's disease ; disease activity index for intestinal Behçet's disease ; Intestinal Behçet's ; Therapeutic regimen</subject><ispartof>Disease-a-month, 2024-01, Vol.70 (1), p.101674-101674, Article 101674</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3</citedby><cites>FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38185603$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manuelyan, Zara</creatorcontrib><creatorcontrib>Butt, Edward</creatorcontrib><creatorcontrib>Parupudi, Sreeram</creatorcontrib><title>Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management</title><title>Disease-a-month</title><addtitle>Dis Mon</addtitle><description>Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by the ileocecal region. Diagnosis is challenging given lack of pathognomonic tests; therefore, it is based on clinical criteria. Management of intestinal BD includes different classes of medications including corticosteroids, 5-aminosalicylic acid, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody agents. In this review, we aim to focus on intestinal BD and provide details of clinical manifestations, diagnosis and therapeutic options of intestinal BD from gastroenterology viewpoint.</description><subject>Behçet's disease</subject><subject>disease activity index for intestinal Behçet's disease</subject><subject>Intestinal Behçet's</subject><subject>Therapeutic regimen</subject><issn>0011-5029</issn><issn>1557-8194</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkE1OwzAQhS0EoqVwBcgOFqTYzp_DrlRQkFqxgbXl2JPWVWJD7CJxIg7CxXBJ6ZbVzHjezBt_CF0QPCaY5DfrsdJOtNb41Zhimvy-FukBGpIsK2JGyvQQDTEmJM4wLQfoxLl1KGmZ4WM0SBhhWY6TIVrMhPOd1caD89qIJrqD1fcX-EsXBQsQDm6jhTC6Dn3htTXuOjTE0linQyqMilphxBJaMP4UHdWicXC2iyP0-nD_Mn2M58-zp-lkHsukID6umCIlFeEyEHkdgpQyrTFjNcmIhESpXJWyIsBKyHOqpKxYUkoqi1TiTEAyQlf93rfOvm_CZbzVTkLTCAN24zgtCWFpyoosSIteKjvrXAc1f-t0K7pPTjDfUuNrvmfJtyx5zzJMnu9MNlULaj_3By8IJr0Awlc_NHTcSQ1GgtIdSM-V1f-a_ADwDItW</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Manuelyan, Zara</creator><creator>Butt, Edward</creator><creator>Parupudi, Sreeram</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240101</creationdate><title>Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management</title><author>Manuelyan, Zara ; Butt, Edward ; Parupudi, Sreeram</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Behçet's disease</topic><topic>disease activity index for intestinal Behçet's disease</topic><topic>Intestinal Behçet's</topic><topic>Therapeutic regimen</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manuelyan, Zara</creatorcontrib><creatorcontrib>Butt, Edward</creatorcontrib><creatorcontrib>Parupudi, Sreeram</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Disease-a-month</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manuelyan, Zara</au><au>Butt, Edward</au><au>Parupudi, Sreeram</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management</atitle><jtitle>Disease-a-month</jtitle><addtitle>Dis Mon</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>70</volume><issue>1</issue><spage>101674</spage><epage>101674</epage><pages>101674-101674</pages><artnum>101674</artnum><issn>0011-5029</issn><eissn>1557-8194</eissn><abstract>Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by the ileocecal region. Diagnosis is challenging given lack of pathognomonic tests; therefore, it is based on clinical criteria. Management of intestinal BD includes different classes of medications including corticosteroids, 5-aminosalicylic acid, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody agents. In this review, we aim to focus on intestinal BD and provide details of clinical manifestations, diagnosis and therapeutic options of intestinal BD from gastroenterology viewpoint.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38185603</pmid><doi>10.1016/j.disamonth.2023.101674</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0011-5029
ispartof Disease-a-month, 2024-01, Vol.70 (1), p.101674-101674, Article 101674
issn 0011-5029
1557-8194
language eng
recordid cdi_proquest_miscellaneous_2911844875
source ScienceDirect Freedom Collection
subjects Behçet's disease
disease activity index for intestinal Behçet's disease
Intestinal Behçet's
Therapeutic regimen
title Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A35%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastrointestinal%20Beh%C3%A7et's%20disease:%20Manifestations,%20diagnosis,%20and%20management&rft.jtitle=Disease-a-month&rft.au=Manuelyan,%20Zara&rft.date=2024-01-01&rft.volume=70&rft.issue=1&rft.spage=101674&rft.epage=101674&rft.pages=101674-101674&rft.artnum=101674&rft.issn=0011-5029&rft.eissn=1557-8194&rft_id=info:doi/10.1016/j.disamonth.2023.101674&rft_dat=%3Cproquest_cross%3E2911844875%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-b8d192a502ea6f502ccc4f088f151ce3dd6d9cb1e89e662dccb839c2c74c05ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2911844875&rft_id=info:pmid/38185603&rfr_iscdi=true